Thermo Fisher Scientific Inc., Catalent, Inc., Clinigen Group plc. is Dominating the Market for Global Clinical Trial Supplies Market in 2017

Global Clinical Trial Supplies Market is expected to grow with the CAGR of 7.8% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below:

Access Full Report Access Full Report: https://databridgemarketresearch.com/reports/global-clinical-trial-supplies-market

Global clinical trial supplies market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global clinical trial supplies market are introducing strong range of products provider along with launching new services and adopting strategic initiatives such as acquisition, agreement, business expansion, award and recognition into the clinical trial supplies market. This helped companies to maximize the sales with enhanced service portfolio. For example, in August 2020, SIRO Clinpharm Private Limited appointed Pitchfork as a strategic communication partner. The partnership is done to expand the business and services of the company with the help of pitchfork values and beliefs. It will help the company in achieving strategic goals for future.

Thermo Fisher Scientific Inc. is the dominating player in global clinical trial supplies market. The other key players existing in the clinical trial supplies market includes Catalent, Inc., Almac Group, Biocair, SIRO Clinpharm Private Limited, Sharp, PCI Pharma Services, MYODERM, Clinigen Group plc., KLIFO, CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC., Bionical Ltd., Parexel International Corporation, Alium Medical Limited, Ancillare, LP and Movianto among others.

Thermo Fisher Scientific Inc.:

Thermo Fisher Scientific Inc. is headquartered in Massachusetts, U.S. and was founded in 1956. The company mainly accelerates towards life science challenges and research improving the diagnostics by providing medicines and laboratory productivity services. The company deals in business segments such as analytical instruments, life science solutions, specialty diagnostics and laboratory products & services in which laboratory products & services is the market focused segment. The company provides various services under categories such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon among which Fisher Scientific is the market focused category.

For instance,

• In August 2020, Thermo Fisher Scientific Inc. has launched a new site for manufacturing of COVID-19 sample collection products. The company has also announced that this site will continue to expand to meet expected sustained demand for COVID-19 clinical studies and testing. This step has helped the company in expanding their services and in meeting the necessary demands of the customers.

The company has wide global presence across the globe such as in North America, Asia-Pacific, Europe and South America. In addition to it, the company also generates its revenue from the various subsidiary companies such as Laboratory Management Systems, Inc. (U.S.), Thermo Fisher Scientific (U.S.) Holding S.a.r.l (Luxembourg), Thermo Fisher Scientific Senior Financing LLC (U.S.), Thermo Fisher Scientific Operating Company LLC (U.S.) and others.

Catalent, Inc:

Catalent, Inc is headquartered in New Jersey, U.S. and was founded in 2007. The major focus of the company is to develop, manufacture and supply products that help people live healthier lives. The company deals in business segments such as softgel technologies, biologics and specialty drug delivery, oral drug delivery and clinical supply services in which clinical supply services is the market focused segment. The company provides various services under categories such as oral dose, biologics, specialty, clinical supply, consumer and expert content among which clinical supply is the market focused category.

For instance,

• In July 2020, Catalent, Inc completed the purchase of Pharmaceutical clinical packaging facility in Japan. This new 60,000 square foot facility will provide customers with flexible clinical supply solutions and global biotech and pharmaceutical companies. This has helped the company in expanding network to ensure customer clinical trials as well served across the region.

The company has wide global presence in North America, Asia-Pacific, Latin America and Europe. In addition to it, the company also generates its revenue from the various subsidiary companies such as Catalent Pharma Solutions Inc. (U.S.), Catalent Japan K.K.(Japan), Catalent Belgium SA (Belgium), Catalent USD Packaging, LLC (U.S.) among others.

Parexel International Corporation:

Parexel International Corporation is headquartered in Massachusetts, U.S. and was founded in 1982. The company is leading in providing of wide range of drug development abilities to the worldwide CROs. The company provides various services under categories such as clinical development, outsourcing services, integrated technologies, regulatory access consulting, medical communications, solutions by industry, solution by development phase, medical and scientific services and real-world evidence and late phase among which clinical development is the market focused category.

For instance,

• In May 2020, Parexel International Corporation joined with ACRO to help administers and overseas COVID-19 testing in the UK. It has helped the company to sustain the position of top leading provider of solutions to accurate the development and delivery of new therapies in the market.

The company has wide global presence in North America, South America, Europe, Middle East and Africa and Asia-Pacific. In addition to it, the company also generates its revenue from the various subsidiary companies such as Perceptive Informatics Inc. (U.K.), PAREXEL International (India) Private Limited (India), PAREXEL MMS Europe Limited (U.K.), PAREXEL International (Thailand) Co Ltd (Thailand), DATALABS INC (U.S.) among others.